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Objectives
Juvenile systemic lupus erythematous (JSLE) is a multi-
system autoimmune disorder of unknown origin. Invol-
vement of the mucocutaneous ,musculoskeletal system
and kidney disease are the most common manifestation
of JSLE. This investigation was performed to define the
demography and clinical manifestation of JSLE in Iran.
Methods
Fifty nine patients with JSLE were enrolled in this retro-
spective study. All patients fulfilled the American Col-
lege of Rheumatology revised criteria 1982 for the
diagnosis of SLE and had shown clinical manifestations
of the disease before the age of 16.
Results
A total of 59 patients, 49 (89%) were female and10
(16.9%) male. The female to male ratio was 4.9:1. The
mean age of onset was 10.5 years (range 2-16). The
mean duration of disease from diagnosis was 2 years
(range7 months-5 years). The most common of consti-
tutional sign was fatigue (76.3%) and the other signs
were fever (32.2%), Nocturnal pain (20.3%), Mood disor-
der (20.03%), and Weight loss (22%). The most common
manifestation of JSLE were as follows: 48 patients
(81.35%) had mucocutaneous involvement, 46 patients
(77.9%) had musculoskeletal involvement, 25 children
(42.37%) suffered from renal disease, hematological
abnormalities were detected in 19 patients (32.2%), 10
patients (16.94%) had cardiovascular disease, 33 patients
(55.93%) presented nervous system involvement, 12
patients (20.33%) had pulmonary disease, and 13
patients (22.03) experienced infection complications.
During the follow up period(3years) two patients died,
one from renal failure, one from infections.
Conclusion
A high index of suspicion must be preserved for the
diagnosis of SLE in adolescent children, particularly
girls. Juvenile systemic lupus erythematous (JSLE) is a
critical multi-system organ disease. JSLE still has a sig-
nificant mortality rate high, although it has a high
remission rate with early diagnosis and treatment.
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